延续性干预模式在乳腺癌癌因性疲乏病人中的应用被引量：20

Application of extended intervention model in breast cancer patients with cancer-related fatigue

在线阅读下载PDF

导出

摘要 [目的]探讨乳腺癌癌因性疲乏病人的延续性干预模式及其应用效果。[方法]选取经病理学证实的乳腺癌病人117例,分为观察组和对照组,对照组病人实施常规护理及出院指导,观察组病人在此基础上实施延续性护理,干预至病人化疗结束时,应用Piper疲乏修订量表评价两组病人癌因性疲乏程度。[结果]干预后,观察组病人癌因性疲乏得分低于对照组,差异有统计学意义(P<0.05)。[结论]延续性干预模式可有效减轻乳腺癌病人的癌因性疲乏。

作者李晓瑾周春兰李文姬吴艳妮

机构地区南方医科大学南方医院

出处《护理研究（下旬版）》 2016年第9期3398-3400,共3页 Chinese Nursing Researsh

基金广东省科技厅科研立项资助课题编号:2015A070709011

关键词乳腺癌癌因性疲乏延续性护理相关因素出院指导

分类号 R473.71 [医药卫生—护理学]

引文网络
相关文献

参考文献9

1Panis C,Cecilio- Da- Silva AP,Takakura ET,et al. Breast cancer in Brazil: epidemiology and treatment challenges[J]. Breast Canc- er: Targets and Therapy, 2015,7(29) : 43 - 49.
2Kroz M, Fink M, Reif M,et al. Multimodal therapy concept and aerobic training in breast cancer patients with chronic cancer - re- lated fatigue[J]. Integrative Cancer Therapies, 2013,12 (4) : 301 - 311.
3Chodosh LA. Breast cancer: current state and future promise[J]. Breast Cancer Research,2011,13(6) :113 - 125.
4Knobel H,Loge JH,Brenne E,et al. Evalidity of EORCT QLQ- C30 fatigue scale in advanced cancer patients and cancer survivors [J]. Palliat Med,2003,17(8) :664 - 672.
5周春兰,仝慧茹,李文姬,马兰兰,吴艳妮,刘清宏.乳腺癌病人癌因性疲乏的诱因分析[J].护理研究（中旬版）,2013,27(3):707-708. 被引量：18
6Jason R.Schwartz,Purvaba J.Sarvaiya,Lily E.Leiva,Maria C.Velez,Tammuella C.Singleton,Lolie C.Yu,Wayne V.Vedeckis.A facile,branched DNA assay to quantitatively measure glucocorticoid receptor auto-regulation in T-cell acute lymphoblastic leukemia[J].Chinese Journal of Cancer,2012,31(8):381-391. 被引量：3
7Min YH,Lee JW,Shin YW,et al. Daily collection of self- repor- ting sleep disturbance data via a smartphone app in breast cancer patients receiving chemotherapy: a feasibility study[J]. Journal of Medical Internet Research,2014,16(5) ..e135.
8张兰凤,叶赟,刘敏杰.延续性护理在癌症出院患者中的实践研究进展[J].中国护理管理,2012,12(11):91-94. 被引量：73
9Wanchai A, Armer JM, Stewart BR. Nonpharmacologic supportive strategies to promote quality of life in patients experiencing cancer - re- lated fatigue: a systematic review[J]. Clin J Oncol Nurs, 2011,15 (2) :203 - 214.

二级参考文献79

1俞桃英.护士对出院患者实施电话随访的体会[J].中华护理杂志,2006,41(3):246-247. 被引量：473
2Langebrake C, Reinhardt D, Ritter J. Minimising the long-term adverse effects of childhood leukaemia therapy. Drug Saf,2002,25:1057-1077.
3Pearson OH, Eliel LP, Rawson, RW, et al. Adrenocorticotropichormone- and cortisone-induced regression of lymphoid tumors in man: a preliminary report. Cancer, 1949,2:943-945.
4Ploner C, Schmidt S, Presul E, et al. Glucocorticoid-induced apoptosis and glucocorticoid resistance in acute lymphoblastic leukemia. J Steroid B iochem Mol Biol, 2005,93:153-160.
5Kaspers G J, Pieters R, Van Zantwijk CH, et al. Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs. Blood, 1998,92:259-266.
6Hulleman E, Kazemier KM, Holleman A, et al. Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells. Blood, 2009,113:2014-2021.
7Den Boer ML, Harms DO, Pieters R, et al. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia. J Clin Oncol, 2003,21:3262-3268.
8Dordelmann M, Reiter A, Borkhardt A, et al. Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. Blood, 1999,94:1209- 1217.
9Hochhauser C J, Lewis M, Kamen BA, et al. Steroid-induced alterations of mood and behavior in children during treatment for acute lymphoblastic leukemia. Support Care Cancer, 2005, t 3:967-974.
10Schimmer BP, Parker KL. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11th ed. New York: McGraw-Hill, 2006:1587-1612.